In honor of the recent Brain Injury Awareness Month in March, the U.S. Army Medical Research and Development Command's Combat Casualty Care Research Program is highlighting a significant achievement within its Neurotrauma Portfolio.
Principally striving to "close military-relevant gaps in combat-related traumatic brain injury from the battlefield through acute hospitalization," the Neurotrauma Portfolio is determined to meaningfully advance the TBI space with both knowledge and materiel solutions. Supplementary efforts include the refinement of clinical practice guidelines, the establishment of individualized approaches to casualty management and the oversight of active clinical trials testing several therapeutics for the acute treatment of TBIs, as well as studies developing technologies to noninvasively diagnose, assess and monitor TBI casualties in the far-forward environment.
